Summit Therapeutics, Inc. (SMMT)
17.90
+2.05
(+12.93%)
USD |
NASDAQ |
May 20, 16:00
17.89
-0.01
(-0.06%)
After-Hours: 20:00
Summit Therapeutics Total Assets (Quarterly) : 647.86M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Revolution Medicines, Inc. | 2.254B |
| BioMarin Pharmaceutical, Inc. | 8.591B |
| Relay Therapeutics, Inc. | 699.61M |
| Alnylam Pharmaceuticals, Inc. | 5.130B |
| Amgen, Inc. | 92.50B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 101.92M |
| Shareholders Equity (Quarterly) | 545.93M |
| Debt to Equity Ratio | 0.0367 |
| Current Ratio | 7.405 |
| Net Debt Paydown Yield | -0.02% |